THE INDIAN PHARMACIST Official Circular Pharmacy LogoTHE INDIAN PHARMACISTLearn. Explore. Practise. Excel.
Pharmacy Law, Regulation & Safe Dispensing ARTICLE ID: KH-29 ⏱️ 10 min read 📅 Updated: 2026-11-10

How to Read a Medicine Label and Strip in India

🎯 Key Takeaways Summary

  • Read the Generic (Proper) Name and exact mg strength first — never rely on brand name or strip colour alone.
  • Look for the Red Vertical Line and Schedule H / H1 / X box to know if a valid prescription is legally mandatory.
  • Scan the QR code on top-300 formulation packs to verify CDSCO track-and-trace authenticity (unique product ID, batch number, and expiry).
  • Check storage instructions ('Store below 25°C / 30°C' vs 'Store in a refrigerator at 2°C–8°C; do not freeze').

1. Foundational Clinical & Scientific Overview

Every medicine strip, blister pack, vial, and carton sold in India is a legal document governed by Rules 96 and 97 of the Drugs and Cosmetics Rules, 1945. Learning how to systematically inspect the 10 mandatory statutory elements on an Indian medicine strip protects patients from look-alike/sound-alike (LASA) dispensing errors, accidental double-dosing of active ingredients, expired medication use, and counterfeit products.

2. Core Mechanisms, Classification & Practical Framework

Under CDSCO's amended Rule 96 (effective 2019), the Generic (Proper) Name of the medicine must be printed in a font size that is AT LEAST TWO FONT POINTS LARGER than the brand/trade name (or in equal prominence as specified by current statutory notifications), ensuring that patients and pharmacists can immediately identify the actual active pharmaceutical ingredient (API).

Structured Classification & Practical Examples

  • 1. Proper (Generic) Name & Pharmacopoeial Standard (IP / BP / USP): Identifies the exact active ingredient(s) and salt form (e.g., 'Metoprolol Succinate Extended-Release Tablets IP 50 mg equivalent to Metoprolol Tartrate 50 mg'). The letters 'IP' confirm compliance with Indian Pharmacopoeia quality standards.
  • 2. Statutory Schedule Symbol & Red Vertical Line: A 1 mm wide vertical red line on the left margin indicates a prescription-only medicine. 'Rx' denotes Schedule H; 'Rx' in red inside a red box denotes Schedule H1; 'NRx' in red denotes Schedule X.
  • 3. Batch / Lot Number, Manufacturing Date (Mfg. Dt.) & Expiry Date (Exp. Dt.): The Expiry Date indicates the final month/year through which the manufacturer guarantees >=90%–100% labelled potency and stability when stored correctly.
  • 4. Manufacturing License Number (Mfg. Lic. No.), Manufacturer vs Marketer Address & Maximum Retail Price (MRP): Distinguishes the actual licensed GMP manufacturing site from the marketing company, and states the NPPA/DPCO-compliant MRP inclusive of all taxes. Top-selling 300 brands also carry a mandatory QR Code (since August 2023) for track-and-trace authenticity verification.

3. Advanced Clinical Pharmacy, Dosing & Indian Regulatory Application

Preventing 'Same-Generic Double Dosing' via Strip Inspection: A frequent medication error in Indian households occurs when a patient takes two differently branded strips (for example, 'Dolo 650' prescribed by one doctor and 'Calpol 650' or an FDC cold tablet containing Paracetamol 500 mg) without reading the generic box, inadvertently exceeding the 4,000 mg/day adult hepatotoxic threshold of Paracetamol. Teaching patients to always read the boxed Generic Name first eliminates duplicate therapy.

4. Common Misunderstandings & Pharmacist Safety Safeguards

⚠️ Clinical Pitfall & Safety Note: Common Misunderstanding: Assuming that the company logo in the largest font is the 'manufacturer' or that two different brand names contain different medicines. Always check the Generic Composition box and the 'Manufactured in India by:' line.

5. Explanatory Visual Pharmacology Diagram (svg-v339-07-routes-of-drug-administration)

ROUTE-SPECIFIC DRUG DELIVERY: ONSET, BIOAVAILABILITY (F) & FIRST-PASS BYPASS 1. Oral (PO) • Onset: 30–90 min • F: Variable (5–99%) • First-Pass: YES (High) Safest, convenient; requires dissolution & portal transit. 2. Sublingual (SL) • Onset: 1–3 min (Rapid) • Drains to SVC directly • First-Pass: BYPASSED e.g. Sublingual GTN 0.5 mg in acute angina pectoris. 3. Buccal Route • Onset: 3–10 min • Cheek pouch mucosa • First-Pass: BYPASSED e.g. Buccal Midazolam, Buprenorphine, Fentanyl. 4. Intravenous (IV) • Onset: 15–60 sec • Bioavailability F = 100% • First-Pass: BYPASSED Strict asepsis & tonicity; irreversible once injected. 5. Intramuscular (IM) • Onset: 10–20 min • F: 75–100% • First-Pass: BYPASSED Deltoid / Vastus lateralis; oily depot formulations. 6. Subcutaneous (SC) • Onset: 15–30 min • Slow sustained absorption • First-Pass: BYPASSED Insulins, Enoxaparin (LMWH); rotate injection sites. 7. Inhalational • Onset: 2–5 min • Particle size 1–5 μm • Targeted Pulmonary Salbutamol, ICS; rinse mouth after ICS to prevent thrush. 8. Transdermal Patch • Onset: Hours (Steady) • Stratum corneum barrier • First-Pass: BYPASSED Fentanyl, GTN, Nicotine, Rivastigmine patches. 9. Topical / Ophthalmic • Local skin/mucosal effect • Minimal systemic toxicity • Nasolacrimal occlusion Timolol eye drops bypass first-pass if absorbed systemically. 10. Rectal (PR) • Onset: 5–30 min • Useful in vomiting/seizure • ~50% First-Pass Bypass Rectal Diazepam in paediatric febrile status epilepticus.
8.7 Route-Specific Drug Delivery: Bioavailability, Onset & First-Pass Comparison Across 10 Routes: Figure 8.7: Comparative biopharmaceutics across 10 routes of administration: Oral, Sublingual, Buccal, Intravenous (IV), Intramuscular (IM), Subcutaneous (SC), Inhalational, Transdermal, Topical, and Rectal.

6. Authoritative References & Editorial Traceability

Primary Reference Sources: Drugs and Cosmetics Rules, 1945 (Rule 96 & Rule 97 Labelling Standards); CDSCO G.S.R. 823(E) Barcode/QR Code Mandate for Top 300 Brands.

Official Portals: CDSCO • Indian Pharmacopoeia Commission (IPC / NFI) • ICMR • FSSAI • NCBI Bookshelf

Educational Disclaimer: Published for pharmacy education, academic learning, and professional clinical reference. Never self-medicate or alter prescribed treatment without consulting a qualified medical practitioner.

← Previous: Herb–Drug Interactions: When Natural Produ... All 40 Articles Next: Generic vs Branded Medicines: What Patient... →